Handa Pharmaceuticals (Taiwan) Buy Hold or Sell Recommendation
| 6620 Stock | TWD 73.70 3.40 4.41% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Handa Pharmaceuticals is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Handa Pharmaceuticals given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Handa Pharmaceuticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Handa Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Handa and provide practical buy, sell, or hold advice based on investors' constraints. Handa Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Handa |
Execute Handa Pharmaceuticals Buy or Sell Advice
The Handa recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Handa Pharmaceuticals. Macroaxis does not own or have any residual interests in Handa Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Handa Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Handa Pharmaceuticals Trading Alerts and Improvement Suggestions
| Handa Pharmaceuticals had very high historical volatility over the last 90 days | |
| The company reported the revenue of 28.86 M. Net Loss for the year was (282.1 M) with profit before overhead, payroll, taxes, and interest of 68.71 M. | |
| Handa Pharmaceuticals has accumulated about 315.09 M in cash with (308.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.72. |
Handa Pharmaceuticals Returns Distribution Density
The distribution of Handa Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Handa Pharmaceuticals' future price movements. The chart of the probability distribution of Handa Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Handa Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Handa Pharmaceuticals returns is essential to provide solid investment advice for Handa Pharmaceuticals.
| Mean Return | 0.14 | Value At Risk | -3.82 | Potential Upside | 6.98 | Standard Deviation | 4.05 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Handa Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Handa Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Handa Pharmaceuticals or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Handa Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Handa stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.14 | |
β | Beta against Dow Jones | -0.15 | |
σ | Overall volatility | 4.06 | |
Ir | Information ratio | 0.03 |
Handa Pharmaceuticals Volatility Alert
Handa Pharmaceuticals currently demonstrates below-average downside deviation. It has Information Ratio of 0.03 and Jensen Alpha of 0.14. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Handa Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Handa Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Handa Pharmaceuticals Fundamentals Vs Peers
Comparing Handa Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Handa Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Handa Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Handa Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Handa Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Handa Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Handa Pharmaceuticals to competition |
| Fundamentals | Handa Pharmaceuticals | Peer Average |
| Return On Equity | -41.47 | -0.31 |
| Return On Asset | -27.2 | -0.14 |
| Current Valuation | 2.86 B | 16.62 B |
| Shares Outstanding | 115.57 M | 571.82 M |
| Price To Book | 8.38 X | 9.51 X |
| Price To Sales | 196.22 X | 11.42 X |
| Revenue | 28.86 M | 9.43 B |
| Gross Profit | 68.71 M | 27.38 B |
| EBITDA | (309.06 M) | 3.9 B |
| Net Income | (282.1 M) | 570.98 M |
| Cash And Equivalents | 315.09 M | 2.7 B |
| Cash Per Share | 2.72 X | 5.01 X |
| Total Debt | 13.36 M | 5.32 B |
| Debt To Equity | 0.02 % | 48.70 % |
| Current Ratio | 10.79 X | 2.16 X |
| Book Value Per Share | 5.85 X | 1.93 K |
| Cash Flow From Operations | (308.47 M) | 971.22 M |
| Earnings Per Share | (2.29) X | 3.12 X |
| Number Of Employees | 9 | 18.84 K |
| Beta | 1.31 | -0.15 |
| Market Capitalization | 5.66 B | 19.03 B |
Handa Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Handa . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Handa Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Handa Pharmaceuticals? Buying financial instruments such as Handa Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Handa Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Steel Works Etc Thematic Idea Now
Steel Works Etc
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Steel Works Etc theme has 54 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Steel Works Etc Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Handa Stock Analysis
When running Handa Pharmaceuticals' price analysis, check to measure Handa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Handa Pharmaceuticals is operating at the current time. Most of Handa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Handa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Handa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Handa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.